uniQure (QURE) Operating Margin Growth (5y) (2021 - 2026)

uniQure (QURE) Operating Margin Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 850,896.00
Dec 31, 2025 -89,382.00
Sep 30, 2025 110,791.00
Jun 30, 2025 165,550.00
Mar 31, 2025 3.06 Mn
Dec 31, 2024 37,858.00
Sep 30, 2024 123,585.00
Jun 30, 2024 79,001.00
Mar 31, 2024 178,202.00
Dec 31, 2023 58,222.00
Sep 30, 2023 -508,152.00
Jun 30, 2023 -199,161.00
Mar 31, 2023 -82,939.00
Dec 31, 2022 90,215.00
Sep 30, 2022 -369,712.00
Jun 30, 2022 -1.09 Mn
Mar 31, 2022 -242,421.00
Dec 31, 2021 18,312.00
Sep 30, 2021 -149,704.00
Jun 30, 2021 150,615.00